High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia

By Tadesse Birkneh Tilahun   Kinloch Natalie N.   Baraki Bemuluyigza   Lapointe Hope R.   Cobarrubias Kyle D.   Brockman Mark A.   Brumme Chanson J.   Foster Byron A.   Jerene Degu   Makonnen Eyasu   Aklillu Eleni   Brumme Zabrina L.  

Viruses, Vol. 10, Iss. 2, 2018-02 ,pp. : 60-60

MDPI

Access to resources Recommend Favorite

Immunological failure of first‐line and switch to second‐line antiretroviral therapy among HIV‐infected persons in Tanzania: analysis of routinely collected national data

By  

TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol. 20, Iss. 7, 2015-07 ,pp. : 880-892

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?

By Mesplède Thibault   Wainberg Mark A.  

Viruses, Vol. 6, Iss. 9, 2014-08 ,pp. : 3377-3385

MDPI

Access to resources Recommend Favorite

Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first‐line combination antiretroviral therapy

By  

HIV MEDICINE, Vol. 16, Iss. 9, 2015-10 ,pp. : 553-562

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improvement in mortality and retention among adult HIV‐infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district,Tanzania.

By  

TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol. 20, Iss. 6, 2015-06 ,pp. : 791-796

John Wiley & Sons Inc

Access to resources Recommend Favorite